Literature DB >> 29708168

International trends in the clinical epidemiology of malignant pleural mesothelioma.

Ronald A M Damhuis1, Jan P van Meerbeeck2.   

Abstract

Entities:  

Year:  2018        PMID： 29708168      PMCID： PMC5906352          DOI： 10.21037/jtd.2018.03.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.

Authors:  R A Damhuis; A Khakwani; H De Schutter; A L Rich; J A Burgers; J P van Meerbeeck
Journal:  Lung Cancer       Date:  2015-05-22       Impact factor: 5.705

2.  Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.

Authors:  Ian Woolhouse; Nick A Maskell
Journal:  Thorax       Date:  2018-03       Impact factor: 9.139

3.  Guarantee-Time Bias and Benefits of Surgery for Pleural Mesothelioma.

Authors:  Steven E Vogl
Journal:  J Clin Oncol       Date:  2018-01-05       Impact factor: 44.544

4.  National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.

Authors:  Sahar A Saddoughi; Zaid M Abdelsattar; Shanda H Blackmon
Journal:  Ann Thorac Surg       Date:  2017-12-07       Impact factor: 4.330

5.  Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.

Authors:  David B Nelson; David C Rice; Jiangong Niu; Scott Atay; Ara A Vaporciyan; Mara Antonoff; Wayne L Hofstetter; Garrett L Walsh; Stephen G Swisher; Jack A Roth; Anne Tsao; Daniel Gomez; Sharon H Giordano; Reza Mehran; Boris Sepesi
Journal:  J Clin Oncol       Date:  2017-08-17       Impact factor: 44.544

6.  Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

Authors:  David B Nelson; David C Rice; Jiangong Niu; Scott M Atay; Ara A Vaporciyan; Mara B Antonoff; Wayne L Hofstetter; Garrett L Walsh; Stephen G Swisher; Jack A Roth; Anne S Tsao; Daniel R Gomez; Sharon H Giordano; Reza J Mehran; Boris Sepesi
Journal:  Eur J Cardiothorac Surg       Date:  2018-05-01       Impact factor: 4.191

7.  Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.

Authors:  Pietro Bovolato; Caterina Casadio; Andrea Billè; Francesco Ardissone; Luigi Santambrogio; Giovanni Battista Ratto; Giuseppe Garofalo; Amedeo Vittorio Bedini; Marina Garassino; Luca Porcu; Valter Torri; Ugo Pastorino
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

8.  Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Hedy L Kindler; Nofisat Ismaila; Samuel G Armato; Raphael Bueno; Mary Hesdorffer; Thierry Jahan; Clyde Michael Jones; Markku Miettinen; Harvey Pass; Andreas Rimner; Valerie Rusch; Daniel Sterman; Anish Thomas; Raffit Hassan
Journal:  J Clin Oncol       Date:  2018-01-18       Impact factor: 44.544

9.  Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.

Authors:  Jennifer L Beebe-Dimmer; Jon P Fryzek; Cecilia L Yee; Tapashi B Dalvi; David H Garabrant; Ann G Schwartz; Shirish Gadgeel
Journal:  Clin Epidemiol       Date:  2016-10-26       Impact factor: 4.790

10.  Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Authors:  Avijit Datta; Rhiannon Smith; Francesca Fiorentino; Tom Treasure
Journal:  Thorax       Date:  2013-06-12       Impact factor: 9.139
  10 in total
  1 in total

1.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.